Products
To promote safety in the peptides market, Finnrick is conducting an aggressive program of testing, procuring a total of 3,808 samples from 140 vendors across 15 products and having them checked for purity and quantity in commercial labs.
| Tests | ||||||
|---|---|---|---|---|---|---|
| Product name | Vendors | Count | Avg | Min | Max | Latest |
| Tirzepatide | 100 | 951 | 2 Jan 2026 | |||
| Semaglutide | 48 | 284 | 30 Dec 2025 | |||
| Retatrutide | 95 | 1209 | 29 Dec 2025 | |||
| BPC-157 | 60 | 376 | 29 Dec 2025 | |||
| CJC-1295 | 41 | 204 | 29 Dec 2025 | |||
| Melanotan II | 33 | 130 | 29 Dec 2025 | |||
| PT-141 | 20 | 60 | 29 Dec 2025 | |||
| Ipamorelin | 43 | 195 | 29 Dec 2025 | |||
| Mazdutide | 10 | 28 | 17 Dec 2025 | |||
| Survodutide | 6 | 23 | 6 Dec 2025 | |||
| Cagrilintide | 10 | 42 | 29 Dec 2025 | |||
| Sermorelin | 5 | 14 | 30 Dec 2025 | |||
| Tesamorelin | 20 | 128 | 29 Dec 2025 | |||
| GHK-Cu | 32 | 177 | 29 Dec 2025 | |||
| TB-500 | 3 | 20 | 29 Dec 2025 | |||
Missing a Product?
We welcome suggestions for vendors and products to test.
OR
Do you have a vial from a batch that's not in this list? Finnrick will test it for free.